SGL Investment Advisors Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 40.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,767 shares of the healthcare conglomerate's stock after selling 1,178 shares during the period. SGL Investment Advisors Inc.'s holdings in UnitedHealth Group were worth $932,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $28,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
UNH has been the topic of several recent research reports. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a research report on Wednesday. Barclays decreased their target price on shares of UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a report on Thursday. Oppenheimer reduced their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the company from $560.00 to $350.00 in a research note on Wednesday. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Six research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $508.38.
Read Our Latest Report on UNH
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $273.96 on Friday. The business has a 50-day moving average of $474.72 and a two-hundred day moving average of $515.82. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a market capitalization of $248.52 billion, a P/E ratio of 17.67, a P/E/G ratio of 1.37 and a beta of 0.56.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the business earned $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.